| 000 | 01681 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515011726.0 | ||
| 264 | 0 | _c20060308 | |
| 008 | 200603s 0 0 eng d | ||
| 022 | _a0149-5992 | ||
| 024 | 7 |
_a10.2337/diacare.29.01.06.dc05-1447 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBril, Vera | |
| 245 | 0 | 0 |
_aLong-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy. _h[electronic resource] |
| 260 |
_bDiabetes care _cJan 2006 |
||
| 300 |
_a68-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAldehyde Reductase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xphysiopathology |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xphysiopathology |
| 650 | 0 | 4 |
_aDiabetic Neuropathies _xdrug therapy |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMotor Neurons _xphysiology |
| 650 | 0 | 4 |
_aNeural Conduction _xphysiology |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 |
_aPeripheral Nerves _xdrug effects |
| 650 | 0 | 4 |
_aPeroneal Nerve _xphysiopathology |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 |
_aPyrazines _xtherapeutic use |
| 650 | 0 | 4 |
_aSpiro Compounds _xtherapeutic use |
| 650 | 0 | 4 |
_aSural Nerve _xphysiopathology |
| 700 | 1 | _aBuchanan, Robert A | |
| 773 | 0 |
_tDiabetes care _gvol. 29 _gno. 1 _gp. 68-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2337/diacare.29.01.06.dc05-1447 _zAvailable from publisher's website |
| 999 |
_c15992584 _d15992584 |
||